exv99

THE CHINA FUND, INC. (CHN)

The Martin Currie
Shanghai team

IN BRIEF


Net asset value per share	US$	21.67
Market price	US$	19.11
Premium/(discount)		(11.81	%)
Fund size	US$	393.3m

Source: State Street Bank and Trust Company



At 30 November 2008		US$ returns


	China Fund NAV			MSCI Golden Dragon*
	%			%
One month		(0.2	)		(3.8	)
Year to date		(51.5	)		(49.7	)
One year		(47.2	)		(46.1	)
Three years %pa		(14.9	)		9.1


Past performance is not a guide to future returns.

Source: State Street Bank and Trust Company. NAV performance.

*		Source for index data: MSCI.

MANAGER’S COMMENTARY

What was unusual about the markets in November was not the volatility — we have had that for some time — but the dispersal in returns. The H-shares rallied by 9% during the month, and A-shares by 11%, while the Hang Seng ended flat and Taiwan fell over 9%, underperforming the Dow Jones. The main distinguishing factor was Beijing’s announcement of a 4-trillion-yuan stimulus package and additional large (108-basis-point) interest rate cut, which particularly benefited companies linked to domestic consumption. Taiwan came up with its own stimulus package, including the wheeze of giving shopping coupons worth NT$3,600 to every man, woman and child, but its stockmarket remains dominated by exporters. Given low trading volumes, H-shares also benefited from short-covering — not a feature in Taiwan, where shorting was banned until the month-end.

The stimulus package, the rate cuts and the many other counter-measures that are being announced on a daily basis are a welcome development. They show that the government is well aware of the severity of the problem; as Hu Jintao said, the crisis ‘is a test of our Party’s capacity to govern’. But all this will only partly cushion the fall in export demand and private investment; there are still plenty of high-price inventories to be worked through before any bounce in commodities will be sustainable. The Fund’s managers met a number of our invested companies during the month who continue to thrive in this difficult environment, either because of the nature of their business (agriculture, education, non-bank finance, internet or infrastructure-related) or location (in central or western China, areas that have so far been less affected by the slowdown). But these are generally not mainline stocks and have limited liquidity, meaning that they are not the initial beneficiaries of a ‘relief rally’. Still, the portfolio is seeing an unprecedented level of buybacks; Intime Department Stores, China Metal, SPG Land, The9, Honghua and Yuanta Financial were all buying stock in November. Natural Beauty is attempting privatisation, an option being considered by a number of the Fund’s portfolio companies.

Further stimulus measures can be expected from the Central Committee’s economic conference next week (tax cuts, stabilisation fund?), which should help to offset the ugly macroeconomic and company numbers ahead. Given worsening export figures, we expect the renminbi to come under pressure to depreciate. Although we expect the actual depreciation to be limited, we have hedged 5% of the portfolio by selling renminbi non-deliverable futures. The collapse of the Korean won is also putting pressure on Taipei to allow the New Taiwanese dollar to depreciate somewhat, so we have put on a similar-sized short position here as well.

INVESTMENT STRATEGY

The Fund is 97% invested with holdings in 63 listed companies and seven unlisted ones.

There was little portfolio turnover in November (this is a difficult time to be trading). We added some shares of ZTE, the supplier of telecom equipment, ahead of the probable year-end granting of 3G licenses. We also bought China Oilfield Services, the share price of which has plummeted with the oil price, although the exploration budget of its parent, CNOOC, looks solid.

The industries that appear to have been hit hardest by the crisis are materials, as the world suddenly moved from overstocking to de-stocking, and technology, much of which is subject to the discretionary spending whims of the now hard-pressed consumer. We consequently escaped from Yieh United Steel, reduced China Rare Earth, and sold out of Asustek and Powertech.

There were no changes to our unlisted portfolio in November, but our largest holding, the rural retailer Huiyan, is a prime beneficiary of the government’s decision to subsidize rural buying of household appliances with a 13% VAT rebate. In contrast, our seaweed-processing company, Bright Moon, has been caught with several months’ inventory of high-priced seaweed, as end-product prices come under pressure.

Chris Ruffle, Martin Currie Inc*


*		Martin Currie Ltd and Heartland Capital Management Ltd (HCML) have established MC China Ltd (MCCL), as a joint venture company, to provide investment management or investment advisory services to the range of China investment products managed by Martin Currie.

MCCL has appointed Martin Currie Investment Management Ltd (MCIM), or its affiliates, as investment manager of Martin Currie’s China investment products. HCML has seconded both Chris Ruffle and Shifeng Ke to MCIM, or its affiliates, on a full time basis with the same roles and responsibilities as if they were full time employees.

30 NOVEMBER 2008

FUND DETAILS


Market cap	US$	346.92m
Shares outstanding		18,153,740
Exchange listed	NYSE
Listing date	July 10, 1992
Listed and direct investment manager	Martin Currie Inc

Source: State Street Bank and Trust Company.

ASSET ALLOCATION

Source: State Street Bank and Trust Company

SECTOR ALLOCATION


	The China			MSCI Golden
	Fund, Inc			Dragon
Consumer discretionary		24.3	%		4.0	%
Consumer staples		20.9	%		2.4	%
Healthcare		11.0	%		—
Financials		10.8	%		33.7	%
Industrials		10.4	%		8.1	%
Information technology		6.9	%		16.8	%
Materials		4.8	%		6.2	%
Energy		3.9	%		8.9	%
Utilities		2.7	%		6.2	%
Telecommunications		1.1	%		13.7	%
Other assets & liabilities		3.4	%		—

Source: State Street Bank and Trust Company. Source for index data: MSCI



PERFORMANCE		(US$ RETURNS)


	NAV			Market price
	%			%
One month		(0.2	)		(3.8	)
Year to date		(51.5	)		(49.7	)
Three years %pa		14.9			9.1

Past performance is not a guide to future returns.

Three year returns are annualised.

Source: State Street Bank and Trust Company

15 LARGEST HOLDINGS (45.8%)


Queenbury Investment (Huiyan )	Consumer discretionary	9.8%
China Huiyuan Juice	Consumer staples	4.3%
Shandong Weigao Group	Healthcare	3.2%
Wumart Stores	Consumer staples	3.1%
Uni-President Enterprises	Consumer staples	3.1%
Chaoda Modern Agriculture	Consumer staples	3.0%
Daqin Railway	Industrials	2.7%
Xinao Gas	Utilities	2.7%
Yuanta Financial	Financials	2.6%
Far Eastern Department Stores	Consumer discretionary	2.4%
Fubon Financials	Financials	1.9%
Qinghai Salt Lake Potash	Materials	1.8%
Qingdao Bright Moon	Industrials	1.8%
Mindray Medical International	Healthcare	1.7%
China Medical System Holdings	Healthcare	1.7%

DIRECT INVESTMENTS (16.6%)


Queenbury Investment (Huiyan)	Consumer discretionary	9.8%
Qingdao Bright Moon	Industrials	1.8%
China Silicon (Series A Preferred)	Information technology	1.7%
Highlight Tech	Industrials	1.5%
Wuxi Paiho	Industrials	0.9%
Sino-Twinwood	Information technology	0.8%
China Silicon	Information technology	0.1%
teco Optronics	Information technology	—

Source: State Street Bank and Trust Company.



FUND PERFORMANCE (BASED ON NET ASSET VALUE)		(US$ RETURNS)


	One			Three			Calendar			One			Three			Five			Since
	month			months			year to date			year			years			years			launch
	%			%			%			%			% pa			% pa			% pa
The China Fund, Inc.		(0.2	)		(32.87	)		(51.5	)		(47.2	)		14.9			9.6			8.8
MSCI Golden Dragon		(1.7	)		(37.3	)		(52.8	)		(53.9	)		(1.8	)		(3.7	)		n/a
Hang Seng China Enterprise		9.0			(37.8	)		(55.0	)		(57.9	)		12.7			13.5			n/a
Shanghai Stock Exchange 180		8.3			(25.7	)		(64.0	)		(59.3	)		32.5			12.8			n/a

Past performance is not a guide to future returns.

Source: State Street Bank and Trust Company. Launch date 10 July 1992. Three year, five year and since launch returns are all annualised.

Source for index data: MSCI for the MSCI Golden Dragon and Copyright 2008 Bloomberg LP for the Hang Seng China Enterprise and the Shanghai Stock Exchange 180. For a full description of each index please see the index descriptions section.

PERFORMANCE IN PERSPECTIVE

Past performance is not a guide to future returns.

Source: Martin Currie Inc as at 30 November 2008.

THE CHINA FUND INC. PREMIUM/DISCOUNT

Past performance is not a guide to future returns.

Source: Martin Currie Inc as at 30 November 2008.

10 YEAR DIVIDEND HISTORY CHART


Total		0.50	0.08	0.11	0.00	0.13	0.21	1.78	3.58	2.51	4.01	12.12
Income		0.50	0.08	0.11	0.00	0.13	0.06	0.07	0.20	0.22	0.30	0.28
Long-term capital	0.00		0.00	0.00	0.00	0.00	0.00	0.67	3.27	2.29	2.73	9.00
Short-term capital	0.00		0.00	0.00	0.00	0.00	0.15	1.04	0.11	0.00	0.98	2.84

Past performance is not a guide to future returns.

Source: State Street Bank and Trust Company.

30 NOVEMBER 2008


Sector	Company (BBG ticker)		Price		Holding		Value US$		% of portfolio
Hong Kong										24.9	%
China Huiyuan Juice	1886	HK	HK$	9.3		14,059,500		16,871,182		4.3	%
Chaoda Modern Agriculture	682	HK	HK$	4.5		20,633,998		11,954,253		3.0	%
Xinao Gas	2688	HK	HK$	8.7		9,286,000		10,460,095		2.7	%
Shangri-La Asia	0069	HK	HK$	10.0		4,755,555		6,136,121		1.5	%
China Shineway Pharmaceutical	2877	HK	HK$	4.2		11,184,000		6,060,928		1.5	%
Huabao International	336	HK	HK$	4.9		9,135,000		5,716,668		1.5	%
Natural Beauty Bio-Technology	157	HK	HK$	1.2		32,780,000		4,948,659		1.3	%
Golden Meditech	8180	HK	HK$	1.2		35,040,000		4,837,718		1.2	%
Anta Sports	2020	HK	HK$	3.2		11,072,000		4,543,033		1.2	%
Ports Design	589	HK	HK$	8.7		3,933,500		4,481,594		1.1	%
Intime Department Store Group	1833	HK	HK$	2.0		12,568,629		3,243,475		0.8	%
FU JI Food & Catering Services	1175	HK	HK$	2.5		8,689,000		2,802,867		0.7	%
Honghua Group	196	HK	HK$	0.9		21,902,000		2,571,686		0.6	%
TPV Technology	903	HK	HK$	1.4		12,728,000		2,299,222		0.6	%
Sinofert	297	HK	HK$	3.5		4,860,000		2,163,456		0.5	%
Fushan International Energy	639	HK	HK$	1.6		10,740,000		2,161,830		0.6	%
Tianjin Development	0882	HK	HK$	2.2		6,756,000		1,882,938		0.5	%
China Travel International	0308	HK	HK$	1.0		10,982,000		1,374,504		0.3	%
Yorkey Optical International	2788	HK	HK$	0.6		16,424,000		1,186,751		0.3	%
SPG Land	1688	HK	HK$	0.8		11,037,000		1,082,324		0.3	%
Chinasoft International	8216	HK	HK$	0.3		19,230,000		843,628		0.2	%
China Rare Earth	769	HK	HK$	0.7		9,144,000		778,705		0.2	%

Singapore										3.7	%
China Fishery Group	CFG	SP	SG$	0.6		12,050,000		4,393,874		1.1	%
Hsu Fu Chi International	HFCI	SP	SG$	0.7		9,484,000		4,244,174		1.1	%
China Milk Products Group	CMILK	SP	SG$	0.4		11,607,000		2,770,259		0.7	%
CDW	CDW	SP	SG$	0.1		60,000,000		1,988,928		0.5	%
China Energy	CEGY	SP	SG$	0.1		12,199,000		1,051,394		0.3	%

Hong Kong ‘H’ shares										9.6	%
Shandong Weigao Group	8199	HK	HK$	11.0		9,004,000		12,779,706		3.2	%
Wumart Stores	995	HK	HK$	6.2		15,126,000		12,139,678		3.1	%
China Oilfield Services	2883	HK	HK$	4.4		8,238,000		4,676,998		1.2	%
ZTE Corp	763	HK	HK$	16.8		2,060,759		4,467,136		1.1	%
Zijin Mining	2899	HK	HK$	2.8		10,408,000		3,760,261		1.0	%
Sichuan Expressway	107	HK	HK$	1.4		742,000		134,037		0.0	%

Taiwan										25.1	%
Uni-President Enterprises	1216	TT	NT$	32.0		12,593,581		12,087,023		3.1	%
Yuanta Financial	2885	TT	NT$	12.7		26,635,545		10,161,658		2.6	%
Far Eastern Department Stores	2903	TT	NT$	16.7		18,511,584		9,286,655		2.4	%
Fubon Financial	2881	TT	NT$	20.0		12,603,000		7,552,941		1.9	%
Ruentex Development	9945	TT	NT$	16.7		12,694,000		6,368,164		1.6	%
Cathay Financial	2882	TT	NT$	35.0		5,993,788		6,211,832		1.6	%
Taiwan Secom	9917	TT	NT$	43.4		4,738,000		6,177,092		1.6	%
Synnex Technology	2347	TT	NT$	34.0		5,937,855		6,055,759		1.5	%
Lien Hwa Industrial	1229	TT	NT$	11.9		15,919,692		5,690,899		1.4	%
China Development Financial	2883	TT	NT$	6.6		27,751,738		5,535,508		1.4	%
FamilyMart	5903	TT	NT$	46.7		3,777,652		5,299,539		1.3	%
China Metal Products	1532	TT	NT$	16.9		9,019,881		4,579,170		1.2	%
Tripod Technology	3044	TT	NT$	31.7		4,402,867		4,192,703		1.1	%
Cyberlink	5203	TT	NT$	108.5		1,183,000		3,855,793		1.0	%
Wah Lee Industrial	3010	TT	NT$	23.6		4,118,821		2,913,822		0.7	%
Merry Electronics	2439	TT	NT$	24.8		3,584,340		2,664,917		0.7	%

United Kingdom										1.7	%
China Medical System Holdings	CMSH	LN	£	1.2		3,623,188		6,588,767		1.7	%

United States										3.5	%
Mindray Medical International	MR	US	US$	18.1		367,000		6,635,360		1.7	%
The9	CMED	US	US$	12.8		356,200		4,573,608		1.1	%
WuXi PharmaTech Cayman	WX	US	US$	6.0		310,190		1,848,733		0.5	%
Far East Energy	FEEC	US	US$	0.1		10,478,634		943,077		0.2	%


Sector	Company (BBG ticker)	Price		Holding		Value US$		% of portfolio
Equity linked securities (‘A’ shares)									11.5	%
Daqin Railway		US$	1.3		8,307,000		10,657,881		2.7	%
Qinghai Salt Lake Potash*		US$	8.1		887,909		7,054,011		1.8	%
Shenzhen Agricultural		US$	1.8		4,000,000		7,011,076		1.8	%
Dalian Zhangzidao Fishery		US$	2.3		2,270,000		5,114,310		1.3	%
Shanghai Zhenhua Port Machinery		US$	1.1		4,462,752		4,708,203		1.2	%
China Yangtze Power*		US$	1.0		4,169,077		4,190,485		1.1	%
Zhejiang Guyuelongshan		US$	1.0		3,582,000		3,616,118		0.9	%
Shanghai International Airport		US$	1.6		1,816,700		2,928,521		0.7	%

Direct									16.6	%
Queenbury Investment (Huiyan)		US$	85,466.7		450		38,459,700		9.8	%
Qingdao Bright Moon		US$	0.2		31,827,172		7,001,978		1.8	%
China Silicon (Series A Preferred)		US$	238.0		27,418		6,525,484		1.7	%
Highlight Tech		US$	1.8		3,366,893		5,993,070		1.5	%
Wuxi Paiho		US$	0.3		11,734,701		3,679,990		0.9	%
Sino-Twinwood		US$	6.1		500,000		3,050,000		0.8	%
China Silicon		US$	2.4		183,396		436,482		0.1	%
teco Optronics			—		1,861,710		—		—

Other assets & liabilities							13,156,437		3.4	%

INDEX DESCRIPTIONS

MSCI Golden Dragon Index

The MSCI Golden Dragon is a free float-adjusted market capitalisation index that is designed to measure equity market performance in the China region. As of May 2005 the MSCI Golden Dragon Index consisted of the following country indices: China, Hong Kong and Taiwan.

Hang Seng China Enterprise Index

The Hang Seng China Enterprise Index is a capitalisation-weighted index comprised of state-owned Chinese companies (H-shares) listed on the Hong Kong Stock Exchange and included in Hans Seng Mainland China index.

Shanghai Stock Exchange 180 Index

The Shanghai Stock Exchange 180 ‘A’ Share Index is a capitalisation-weighted index. The index tracks the daily price performance of the 180 most representative ‘A’ share stocks listed on the Shanghai Stock Exchange.

OBJECTIVE

The investment objective of the Fund is to achieve long term capital appreciation. The Fund seeks to achieve its objective through investment in the equity securities of companies and other entities with significant assets, investments, production activities, trading or other business interests in China or which derive a significant part of their revenue from China.

The Board of Directors of the Fund has adopted an operating policy of the Fund, effective 30 June 2001, that the Fund will invest at least 80% of its assets in China companies. For this purpose, “China companies” are (i) companies for which the principal securities trading market is in China; (ii) companies for which the principal securities trading market is outside of China or in companies organised outside of China, that in both cases derive at least 50% of their revenues from goods or services sold or produced, or have a least 50% of their assets in China; or (iii) companies organised in China. Under the policy, China will mean the People’s Republic of China, including Hong Kong, and Taiwan. The Fund will provide its stockholders with at least 60 days’ prior notice of any change to the policy described above.

The Fund is subject to the Investment Company Act of 1940 which limits the means in which it can access the ‘A’ share market. The Fund will continue to seek the most efficient way in which to increase its ‘A’ share exposure ensuring ongoing compliance with its legal and regulatory obligations.

CONTACTS

The China Fund, Inc.
c/o State Street Bank and Trust Company
2 Avenue de Lafayette
PO Box 5049
Boston, MA 02206-5049
Tel: (1) 888 CHN-CALL (246 2255)
www.chinafundinc.com

Important information: This document is issued and approved by Martin Currie Inc (MC Inc), as investment adviser of The China Fund Inc (the Fund). MC Inc is authorised and regulated by the Financial Services Authority (FSA) and incorporated under limited liability in New York, USA. Registered in Scotland (No BR2575), registered address Saltire Court, 20 Castle Terrace, Edinburgh, EH1 2ES. Information herein is believed to be reliable but has not been verified by MC Inc. MC Inc makes no representation or warranty and does not accept any responsibility in relation to such information or for opinion or conclusion which the reader may draw from the newsletter.

Martin Currie Ltd and Heartland Capital Management Ltd (HCML) have established MC China Ltd (MCCL), as a joint venture company, to provide investment management or investment advisory services to our China product. MCCL has appointed Martin Currie Investment Management Ltd (MCIM), or its affiliates, as investment manager of our China funds. HMCL has seconded both Chris Ruffle and Shifeng Ke to MCIM or its affiliates on a full time basis with the same roles and responsibilities as if they were full time employees.

The Fund is classified as a ‘non-diversified’ investment company under the US Investment Company Act of 1940 as amended. It meets the criteria of a closed ended US mutual fund and its shares are listed on the New York Stock Exchange. MC Inc has been appointed investment adviser to the Fund.

Investors are advised that they will not generally benefit from the rules and regulations of the United Kingdom Financial Services and Markets Act 2000 and the FSA for the protection of investors, nor benefit from the United Kingdom Financial Services Compensation Scheme, nor have access to the Financial Services Ombudsman in the event of a dispute. Investors will also have no rights of cancellation under the FSA’s Conduct of Business Sourcebook of the United Kingdom.

This newsletter does not constitute an offer of shares. MC Inc, its ultimate and intermediate holding companies, subsidiaries, affiliates, clients, directors or staff may, at any time, have a position in the market referred to herein, and may buy or sell securities, currencies, or any other financial instruments in such markets. The information or opinion expressed in this newsletter should not be construed to be a recommendation to buy or sell the securities, commodities, currencies or financial instruments referred to herein.

The information provided in this report should not be considered a recommendation to purchase or sell any particular security. There is no assurance that any securities discussed herein will remain in an account’s portfolio at the time you receive this report or that securities sold have not been repurchased.

It should not be assumed that any of the securities transactions or holdings discussed here were or will prove to be profitable, or that the investment recommendations or decisions we make in the future will be profitable or will equal the investment performance of the securities discussed herein.

Investing in the Fund involves certain considerations in addition to the risks normally associated with making investments in securities. The value of the shares issued by the Fund, and the income from them, may go down as well as up and there can be no assurance that upon sale, or otherwise, investors will receive back the amount originally invested. There can be no assurance that you will receive comparable performance returns, or that investments will reflect the performance of the stock examples contained in this document. Movements in foreign exchange rates may have a separate effect, unfavorable as well as favorable, on the gain or loss otherwise experienced on an investment. Past performance is not a guide to future returns. Accordingly, the Fund is only suitable for investment by investors who are able and willing to withstand the total loss of their investment. In particular, prospective investors should consider the following risks:

è		The companies quoted on Greater Chinese stock exchanges are exposed to the risks of political, social and religious instability, expropriation of assets or nationalisation, rapid rates of inflation, high interest rates, currency depreciation and fluctuations and changes in taxation, which may affect income and the value of investments.

è		At present, the securities market and the regulatory framework for the securities industry in China is at an early stage of development. The China Securities Regulatory Commission (CSRC) is responsible for supervising the national securities markets and producing relevant regulations. The Investment Regulations, under which the Fund invests in the People’s Republic of China (PRC) and which regulate repatriation and currency conversion, are new. The Investment Regulations give CSRC and State Administration of Foreign Exchange (SAFE) wide discretions and there is no precedent or certainty as to how these discretions might be exercised, either now or in the future. The Fund may, from time to time, obtain access to the securities markets in China via Access Products. Such products carry additional risk and may be less liquid than the underlying securities which they represent.

è		During the past 15 years, the PRC government has been reforming the economic and political systems of the PRC, and these reforms are expected to continue, as evidenced by the recently announced changes. The Fund’s operations and financial results could be adversely affected by adjustments in the PRC’s state plans, political, economic and social conditions, changes in the policies of the PRC government such as changes in laws and regulations (or the interpretation thereof), measures which may be introduced to control inflation, changes in the rate or method of taxation, imposition of additional restrictions on currency conversion and the imposition of additional import restrictions.

è		PRC’s disclosure and regulatory standards are in many respects less stringent than standards in certain Organisation for Economic Co-operation and Development (OECD) countries, and there may be less publicly available or less reliable information about PRC companies than is regularly published by or about companies from OECD countries.

è		The Shanghai Stock Exchange and Shenzhen Stock Exchange have lower trading volumes than most OECD exchanges and the market capitalisations of listed companies are small compared to those on more developed exchanges in developed markets. The listed equity securities of many companies in the PRC are accordingly materially less liquid, subject to greater dealing spreads and experience materially greater volatility than those of OECD countries. These factors could negatively affect the Fund’s NAV.

è		The Fund invests primarily in securities denominated in other currencies but its NAV will be quoted in US dollars. Accordingly, a change in the value of such securities against US dollars will result in a corresponding change in the US dollar NAV.

è		The marketability of quoted shares may be limited due to foreign investment restrictions, wide dealing spreads, exchange controls, foreign ownership restrictions, the restricted opening of stock exchanges and a narrow range of investors. Trading volume may be lower than on more developed stockmarkets, and equities are less liquid. Volatility of prices can also be greater than in more developed stockmarkets. The infrastructure for clearing, settlement and registration on the primary and secondary markets may be underdeveloped. Under certain circumstances, there may be delays in settling transactions in some of the markets.

è		The value of the Fund’s investment in any Quota will be affected by taxation levied against the relevant Qualified Foreign Institutional Investors (QFIIs) or in respect of investments held in the relevant Quotas. The PRC taxation regime that will apply to QFIIs and investments made in or through QFII quotas is not clear. The Investment Regulations are new and do not currently expressly contemplate the treatment of QFIIs and investment made through QFII Quotas.

Martin Currie Inc, registered in Scotland (no BR2575)

Registered office: Saltire Court, 20 Castle Terrace, Edinburgh EH11 2ES Tel: 44 (0) 131 229 5252 Fax: 44 (0) 131 228 5959 www.martincurrie.com/china
North American office: 1350 Avenue of the Americas, Suite 3010, New York, NY 10019, USA Tel: (1) 212 258 1900 Fax: (1) 212 258 1919

Authorised and registered by the Financial Services Authority and incorporated with limited liability in New York, USA.
Please note: calls to the above numbers may be recorded.